PhRMA Statement on Cost Sharing

Washington, D.C. (July 22, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement on copayments for medicines:

Pharmaceutical Marketing in Perspective

Partnership for Prescription Assistance Provides Trusted, Reliable and Free Help to Struggling Americans

Washington, DC (May 6, 2009) – In this period of economic uncertainty, many uninsured and underinsured Americans are going online to seek help getting the prescription medicines they need. America’s pharmaceutical research and biotechnology companies want patients to know that they can rely on the Partnership for Prescription Assistance (PPA) to help them confidentially – and for free.

PhRMA Commends SCHIP Passage In Letter to House Speaker Nancy Pelosi

Washington, D.C. (January 14, 2009) — The track record of success demonstrated by the State Children’s Health Insurance Program (SCHIP) would be continued – and expanded – by passage of the Children’s Health Insurance Program Reauthorization Act of 2009, said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America, in a letter sent today to Speaker of the House Nancy Pelosi.

PhRMA Statement on Health Care Reform Ad

Washington, D.C. (January 8, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding PhRMA’s co-sponsorship of an advertisement promoting effective health care reform:

Payers Influence Which Medicines Patients Receive

Source: PhRMA analysis of annual reports from Pharmacy Benefit Managers. See for example: Medco Drug Trend Reports (2007–2009).

The Facts About Pharmaceutical Marketing and Promotion

Corporate Philanthropy in Asia

Medicare’s Prevention and Drug Benefits

Why Patients Need a Choice of Medicines

Pages

Subscribe to RSS - Access